Medicare Compliance & Reimbursement - 2014 Issue 7
Part B Coding Coach: Alleviate Your Chemo Injection and Infusion Coding Stress With This Expert Advice
Subscribe or sign in to view the full article.
Article Overview
This article explains the general framework for reporting chemotherapy administration services in Part B settings. It is aimed at coders, billers, and reimbursement staff who need a high-level understanding of route-based coding considerations, modifier application, separate E/M reporting, related HCPCS drug billing, and the distinction between chemotherapy administration and other infusion categories. It also notes the relevance of CMS billing guidance for facility and professional claims.
Why This Topic Matters
Chemotherapy administration coding is sensitive to route, timing, sequencing, and documentation, so a clear overview helps reduce claim errors and support consistent reporting across professional and facility contexts.
Article Sections
-
Confirm Route of Administration
Introduces the initial coding decision point for chemotherapy administration based on the route used. It also covers broad distinctions among administration methods and the need to verify the administered substance category.
-
Count Lesions for Intralesional Route
Discusses intralesional chemotherapy administration at a high level and the need to consider lesion count. The section also includes related drug reporting examples.
-
Check Drugs for IV Push Technique
Covers intravenous push chemotherapy administration and how sequencing of substances affects reporting. It also references associated drug billing considerations.
-
Watch Time in IV Infusions
Addresses infusion timing as a general driver for chemotherapy administration reporting. The section includes sequential infusion concepts and related drug quantity reporting.
-
Check if Modifiers Apply
Summarizes situations in which modifiers may be considered for chemotherapy administration claims. The emphasis is on same-day distinct services and multiple IV access circumstances.
-
Know When You Can Report a Separate E/M Code
Explains the relationship between chemotherapy administration and separately reportable evaluation and management services. It also discusses documentation considerations and office visit coding at a broad level.
-
Report Chemo Codes When Appropriate
Describes the general scope of chemotherapy administration code applicability across different clinical contexts. It also notes which broad categories of agents and settings are discussed in the article.
-
Chemotherapy Administration is Complex
Provides background on why chemotherapy administration is treated as complex compared with other infusion services. It includes broad discussion of staff competency, monitoring, preparation, and facility-setting considerations.
What You Will Learn
- How the article organizes chemotherapy administration coding decisions by route and service type
- What broad documentation and modifier topics are discussed for chemo administration claims
- How the article distinguishes chemotherapy administration from other infusion categories
- What general coding areas are covered for related drug billing and separate E/M reporting
- What facility-setting and CMS guidance topics are mentioned in connection with chemo administration
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance staff
- Physician practice administrators
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com